Re: Farmas USA
Re: Farmas USA
Je je
BCE baja tipos tb
Mirad el EUR/USD :))))
Re: Farmas USA
Re: Farmas USA
Re: Farmas USA
NAVB
Acuerdo con Hainan Sinotau Pharmaceuticalpara el desarrollo y la comerciacilización de Lymphoseek en China.
Re: Farmas USA
CLSN
Resultados positivos de dos estudios de fase I
http://investor.celsion.com/releaseDetail.cfm?ReleaseID=869150
Data from the two Phase I studies published in this peer-reviewed journal demonstrate that in heavily pretreated patients with unresectable recurrent chest wall breast cancer (RCWBC), treatment with 50 mg/m² of ThermoDox® combined with mild local hyperthermia is safe and produces objective responses in heavily pretreated RCWBC patients, a particularly difficult-to-treat patient population
The rate of overall local response was 48%, with five patients (17%) achieving complete local responses and nine patients (31%) having partial local responses
http://investor.celsion.com/releaseDetail.cfm?ReleaseID=869150